Latest News

Manipulating dose, timing of two therapies reduces relapse in mouse models of breast cancer

Changing the standard dose and timing of two therapies greatly cut tumor relapse and reduced side effects in mouse models of kinase mutated breast cancer and lung cancer, UT Southwestern Simmons Cancer Center researchers have found.

Source link

Related posts

La Conférence d’Hégra des lauréats du prix Nobel 2020 est inaugurée à Al-ʿUla, en Arabie Saoudite


Medical News Today: Common foods alter gut bacteria by influencing viruses


Philippine FDA slammed for ‘outdated, erroneous’ view on e-cigarettes


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy